Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (16)

« Back to Publications

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Drennan PG. et al, (2025), Lancet Microbe, 6

Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response

Drennan PG. et al, (2024)

Mycobacterium Tuberculosis Transmission in Birmingham, UK, 2009-19: A Prospective Observational Study

Walker TM. et al, (2023)

In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review.

Drennan PG. et al, (2023), Clin Transl Sci, 16, 357 - 382

In vivo human keyhole limpet haemocyanin challenge in early phase drug development: A systematic review

Drennan P. et al, (2022), Clinical and Translational Science

Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels.

Gu Q. et al, (2022), J Infect, 85, 382 - 389

Mycobacterium tuberculosis transmission in Birmingham, UK, 2009-19: An observational study.

Walker TM. et al, (2022), Lancet Reg Health Eur, 17

Assessment of a vancomycin dosing guideline and identification of predictive factors associated with dose and drug trough levels

Gu Q. et al, (2022)

Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid.

Drennan PG. et al, (2021), Br J Clin Pharmacol, 87, 4681 - 4690

Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.

Narayan SW. et al, (2021), Crit Care Med, 49, e952 - e960

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.

Lumley SF. et al, (2021), Clin Infect Dis, 73, e699 - e709

Bayesian Forecasting for Intravenous Tobramycin Dosing in Adults With Cystic Fibrosis Using One Versus Two Serum Concentrations in a Dosing Interval.

Drennan PG. et al, (2021), Ther Drug Monit, 43, 505 - 511

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.

Eyre DW. et al, (2020), Elife, 9

Differential occupational risks to healthcare workers from SARS-CoV-2: A prospective observational study

Eyre DW. et al, (2020)

The dosing and monitoring of vancomycin: what is the best way forward?

Drennan PG. et al, (2019), Int J Antimicrob Agents, 53, 401 - 407

Load More